C. Lecoffre, L'accident vasculaire cérébral en France : patients hospitalisés pour AVC en, p.11, 2008.

C. Lecoffre, Mortalité par accident vasculaire cérébral en France en, p.6, 2008.

, National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke, N Engl J Med, vol.14, issue.24, pp.1581-1588, 1995.

J. M. Wardlaw, G. Zoppo, T. Yamaguchi, and E. Berge, Thrombolysis for acute ischaemic stroke, Cochrane Database Syst Rev, issue.3, p.213, 2003.

M. Saqqur, K. Uchino, A. M. Demchuk, C. A. Molina, Z. Garami et al., Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke, Stroke. mars, vol.38, issue.3, pp.948-54, 2007.

D. Silva, D. A. Brekenfeld, C. Ebinger, M. Christensen, S. Barber et al., The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET), Stroke. févr, vol.41, issue.2, pp.295-304, 2010.

T. Tomsick, J. Broderick, J. Carrozella, P. Khatri, M. Hill et al., Revascularization results in the Interventional Management of Stroke II trial, AJNR Am J Neuroradiol. mars, vol.29, issue.3, pp.582-589, 2008.

O. A. Berkhemer, P. Fransen, D. Beumer, L. A. Van-den-berg, H. F. Lingsma et al., A randomized trial of intraarterial treatment for acute ischemic stroke, N Engl J Med. 1 janv, vol.372, issue.1, 2015.

M. Goyal, B. K. Menon, W. H. Van-zwam, D. Dippel, P. J. Mitchell et al., Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials, Lancet Lond Engl. 23 avr, vol.387, pp.1723-1754, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01876049

J. Alvarez-sabín, C. A. Molina, J. Montaner, J. F. Arenillas, R. Huertas et al., Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients, Stroke. mai, vol.34, issue.5, pp.1235-1276, 2003.

M. Ribo, C. Molina, J. Montaner, M. Rubiera, R. Delgado-mederos et al., Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients, Stroke. août, vol.36, issue.8, pp.1705-1714, 2005.

F. Fierini, A. Poggesi, and L. Pantoni, Leukoaraiosis as an outcome predictor in the acute and subacute phases of stroke, Expert Rev Neurother, vol.17, issue.10, pp.963-75, 2017.

M. Uyttenboogaart, M. W. Koch, K. Koopman, P. C. Vroomen, G. J. Luijckx et al., Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke, J Neurol. juin, vol.255, issue.6, p.80, 2008.

A. Charidimou, G. Turc, C. Oppenheim, S. Yan, J. F. Scheitz et al., Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis: Individual Patient Data Meta-Analysis. Stroke, 2017.

E. Tandberg-askevold, H. Naess, and L. Thomassen, Predictors for recanalization after intravenous thrombolysis in acute ischemic stroke, J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc. févr, vol.16, issue.1, p.4, 2007.

D. Hou, J. Liu, R. Feng, Y. Gao, Y. Wang et al., The role of high-sensitivity C-reactive protein levels in functional outcomes in patients with large-artery atherosclerosis and small-artery occlusion, Neurol Res, 2017.

L. Lassalle, G. Turc, M. Tisserand, S. Charron, P. Roca et al., ASPECTS (Alberta Stroke Program Early CT Score) Assessment of the Perfusion-Diffusion Mismatch, Stroke, vol.47, issue.10, pp.2553-2561, 2016.

S. Kamran, V. Bates, R. Bakshi, P. Wright, W. Kinkel et al., Significance of hyperintense vessels on FLAIR MRI in acute stroke, Neurology. 25 juill, vol.55, issue.2, p.9, 2000.

F. Fazekas, J. B. Chawluk, A. Alavi, H. I. Hurtig, and R. A. Zimmerman, MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging, AJR Am J Roentgenol. août, vol.149, issue.2, pp.351-357, 1987.

A. Rai, B. Cline, E. Williams, J. Carpenter, and T. Roberts, Intravenous thrombolysis outcomes in patients presenting with large vessel acute ischemic strokes--CT angiography-based prognosis, J Neuroimaging Off J Am Soc Neuroimaging. avr, vol.25, issue.2, p.42, 2015.

J. M. Wardlaw, V. Murray, E. Berge, D. Zoppo, and G. J. , Thrombolysis for acute ischaemic stroke

, Cochrane Database Syst Rev, issue.4, p.213, 2009.

S. Padma and M. Majaz, Intra-arterial versus intra-venous thrombolysis within and after the first 3 hours of stroke onset, Arch Med Sci AMS. 30 juin, vol.6, issue.3, pp.303-318, 2010.

N. Wahlgren, N. Ahmed, N. Eriksson, F. Aichner, E. Bluhmki et al., Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST), Stroke. déc, vol.39, issue.12, pp.3316-3338, 2008.

G. Saposnik, B. Young, B. Silver, D. Legge, S. Webster et al., Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome, JAMA, vol.292, issue.15, pp.1839-1883, 2004.

J. Emberson, K. R. Lees, P. Lyden, L. Blackwell, G. Albers et al., Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials, Lancet Lond Engl, vol.29, issue.9958, p.35, 1929.

N. K. Mishra, N. Ahmed, G. Andersen, J. A. Egido, P. J. Lindsberg et al.,

, Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive, BMJ, vol.23, p.6046, 2010.

M. Luitse, G. J. Biessels, G. Rutten, and L. J. Kappelle, Diabetes, hyperglycaemia, and acute ischaemic stroke, Lancet Neurol. mars, vol.11, issue.3, pp.261-71, 2012.

M. W. Parsons, P. A. Barber, P. M. Desmond, T. A. Baird, D. G. Darby et al., Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study, Ann Neurol. juill, vol.52, issue.1, pp.20-28, 2002.

T. K. Nordt, K. J. Klassen, D. J. Schneider, and B. E. Sobel, Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis, Arterioscler Thromb J Vasc Biol. déc, vol.13, issue.12, pp.1822-1830, 1993.

J. Auwerx, R. Bouillon, D. Collen, and J. Geboers, Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus, Arterioscler Dallas Tex. févr, 1988.

I. Juhan-vague, C. Roul, M. C. Alessi, J. P. Ardissone, M. Heim et al., Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients--relationship with plasma insulin, Thromb Haemost. 30 juin, vol.61, issue.3, pp.370-373, 1989.

A. Pandolfi, A. Giaccari, C. Cilli, M. M. Alberta, L. Morviducci et al., Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat, Acta Diabetol, vol.38, issue.2, pp.71-77, 2001.

A. Bruno, V. L. Durkalski, C. E. Hall, R. Juneja, W. G. Barsan et al., The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial protocol: a randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke, Int J Stroke Off J Int Stroke Soc. févr, vol.9, issue.2, p.51, 2014.

, DEUXIEME PARTIE Article publié en anglais dans la revue Mathews Journal of Emergency Medicine, vol.16, 2018.

, Predictors of clinical Outcome after Intravenous Thrombolysis in Ischemic Stroke without Large Vessel Occlusion : The Role of Admission Glycemia